AMRS News 4.01 07/15/2014 04:33:01 Amyris Inc (AMRS)
Post# of 273333
Posted On: 07/15/2014 5:33:02 AM
Amyris Inc (AMRS) 4.01 $AMRS
Brazilian Airline GOL to Make First International Commercial Flights With Newly Approved Amyris-Total Aviation Biofuel
GlobeNewswire - Wed Jul 09, 7:00AM CDT
Amyris (Nasdaq:AMRS) has partnered with Brazilian airline GOL (NYSE:GOL) to begin the first commercial route with farnesane, the recently approved renewable jet fuel.
Should Amyris Investors Fear Intrexon's Farnesene?
Maxx Chatsko, The Motley Fool - Motley Fool - Mon Jul 07, 1:09PM CDT
When a company commercializes a building-block molecule with dozens, if not hundreds, of potential commercial uses, competition is bound to arrive sooner or later. When it comes to farnesene production, that competition may show up sooner than ...
What's the Value of Amyris' Molecule Development Strategy?
Maxx Chatsko, The Motley Fool - Motley Fool - Wed Jun 18, 11:50AM CDT
Artemisinin-based combination therapies are some of the most important weapons wielded by the developing world against malaria, which claims over 620,000 lives each year. While artemisinin is effective, its supply and cost is greatly affected by...
2014 Report on the International Synthetic Biology (Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms, DNA Synthesis, Oligonucleotide Synthesis) Market - Trends and Forecast to 2019
M2 - Wed Jun 18, 5:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9bcz55/synthetic_biology) has announced the addition of the "2014 Report on the International Synthetic Biology (Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms, DNA Synthesis, Oligonucleotide Synthesis) Market - Trends and Forecast to 2019" report to their offering. Synthetic biology defined as the synthesis of artificial or natural components in order to form new artificial living system by re-molding existing biological elements. It aims to attain new preferred functions of artificially modified organisms intended for high yield production of biological systems. Synthetic biology plays an important role in the field of life sciences by developing cheap synthesis procedures. Increasing scientific research coupled with introduction of advanced technologies in synthetic biology will drive the growth of this market. The market for synthetic biology is segmented as: by products, by technologies and by applications. Product segment includes core products and enabling products. Core product segment comprises synthetic DNA, synthetic genes, synthetic cells, XNA and chassis organisms. While enabling products are segmented into DNA and oligonucleotide synthesis products. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Synthetic Biology Market, by Products Chapter 5 Global Synthetic Biology Market, by Technologies Chapter 6 Global Synthetic Biology Market, by Applications Chapter 7 Global Synthetic Biology Market, by Geography Chapter 8 Competitive Landscape Chapter 9 Recommendations Chapter 10 Company Profiles Companies Mentioned: - Agrivida, Inc. - Amyris, Inc. - Algenol Biofuels, Inc. - ATG:biosynthetics GmbH - Bayer AG - Bristol-Myers Squibb - BIONEER CORPORATION - Biosearch Technologies, Inc. - CBC Comprehensive Biomarker Center GmbH - Cobalt Technologies - DuPont, Inc. - Evolva SA - Exxon Mobil Corporation - Ginkgo Bioworks - GeneWorks Pty Ltd. - Genomatica, Inc. - GeneScript Corporation - Gevo, Inc. - Green Biologics Limited - New England Biolabs, Inc. - OriGene Technologies, Inc. - REG Life Sciences, LLC - Royal DSM - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/9b...ic_biology
Amyris Up 5.2%, Shares Break Through Resistance (AMRS)
Comtex SmarTrend(R) - Tue Jun 17, 11:39AM CDT
Amyris (NASDAQ:AMRS) is one of today's best performing low-priced stocks, up 5.2% to $3.85 on 1.2x average daily volume. Thus far today, Amyris has traded 326,000 shares, vs. average volume of 269,000 shares per day. The stock has outperformed the Dow (5.2% to the Dow's 0.1%) and outperformed the S&P 500 (5.2% to the S&P's 0.1%) during today's trading.
Total and Amyris Renewable Jet Fuel Ready for Use in Commercial Aviation
GlobeNewswire - Mon Jun 16, 6:55AM CDT
With the newly revised ASTM standard for jet fuel, Amyris (Nasdaq:AMRS) and Total (CAC:TOTF.PA) today begin to prepare to market a drop-in jet fuel that contains up to 10% blends of renewable farnesane.
A Warning for Biofuel Investors
Shamus Funk, The Motley Fool - Motley Fool - Thu Jun 12, 9:57AM CDT
It's hard to believe a company producing and selling shark liver oil and low-friction tire rubber could be telling a story that we've already heard before, but Amyris ' tale is one not unseen in the bio-product industry. Like a poorly written...
Takasago and Amyris to Begin Commercialization of Novel Fragrance Products
GlobeNewswire - Mon Jun 09, 6:12AM CDT
Takasago (TYO:4914), a global leader in the creation of flavors and fragrances for consumer products, and Amyris (Nasdaq:AMRS), a leading renewable products company, today announced the start of the next phase of their relationship to commercialize farnesene-derived fragrance molecules. Having successfully completed feasibility testing, Takasago agreed to move forward with commercialization, starting with a first purchase for scale-up this quarter.
The Good, the Bad, and the Ugly From Amyris' Financing Deal
Maxx Chatsko, The Motley Fool - Motley Fool - Wed May 28, 3:39PM CDT
Here's a list of words that were not uttered during the first-quarter conference call of synthetic biology leader Amyris on May 8: "Financing" "Convertible debt notes" "$90 million" Although it wasn't discussed on the call, the company...
Why Amyris Inc's Shares Jumped Today
Travis Hoium, The Motley Fool - Motley Fool - Fri May 23, 4:55PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Amyris Inc jumped 12% today after...
Amyris Prices $75 Million Convertible Senior Notes Due 2019
GlobeNewswire - Fri May 23, 6:00AM CDT
Amyris, Inc. (Nasdaq:AMRS) today announced that it has priced $75 million aggregate principal amount of 6.50% Convertible Senior Notes due 2019 (the "notes"
. The notes will be sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. Amyris also granted the initial purchaser of the notes an option to purchase up to an additional $15 million aggregate principal amount of the notes. The sale is expected to close on May 29, 2014, subject to customary closing conditions.
Why Amyris, Total SA, and The Boeing Company Are Excited About Renewable Jet Fuel
Maxx Chatsko, The Motley Fool - Motley Fool - Thu May 22, 8:42AM CDT
Boeing 777 aircraft (and more) around the world could soon be powered in part by renewable fuels. Source: United Airlines / Wikimedia Commons . The global aviation industry accounts for roughly 2% of all greenhouse gas emissions. On a per-passenger...
Amyris to Offer $75 Million Convertible Senior Notes Due 2019
GlobeNewswire - Thu May 22, 6:37AM CDT
Amyris, Inc. (Nasdaq:AMRS), a leading renewable chemicals and fuels company, today announced that it proposes to offer $75 million aggregate principal amount of Convertible Senior Notes due 2019 (the "notes" , subject to market conditions and other factors. The notes are to be offered and sold in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. Amyris also intends to grant to the initial purchaser of the notes an option to purchase up to an additional $15 million aggregate principal amount of notes.
Can Amyris Walk Its Risky Tightrope and Reward Investors?
Maxx Chatsko, The Motley Fool - Motley Fool - Thu May 15, 10:38AM CDT
Synthetic biology pioneer Amyris and its investors discovered several errors in the initial approach to start and ramp the company's wholly owned facility in Brotas, Brazil. While those problems would have been exposed with or without a pristine...
Why Amyris Inc's Shares Popped Today
Travis Hoium, The Motley Fool - Motley Fool - Fri May 09, 5:24PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of renewable products company Amyris Inc ...
Amyris Reports First Quarter 2014 Financial Results
GlobeNewswire - Thu May 08, 3:48PM CDT
-- Strong operating performance with combined inflows from product sales and collaboration inflows of $17.9 million
Amyris Receives Roundtable on Sustainable Biomaterials (RSB) Sustainability Certification
GlobeNewswire - Wed May 07, 9:14AM CDT
Amyris, Inc. (Nasdaq:AMRS) has completed the Roundtable on Sustainable Biomaterials (RSB) certification process and has earned one of the most respected sustainability certifications in the world.
4 Stocks Under $10 Making Big Moves
at The Street - Wed Apr 02, 5:00AM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Why Amyris (AMRS) Shares Are Jumping Today
at The Street - Tue Apr 01, 3:00PM CDT
Shares of Amyris (AMRS) are jumping Tuesday following a report from the United States Maritime Administration that compared an Amyris Renewable Diesel Fuel mixture to regular ultralow sulfur diesel fuel, and found reduced air emission with not...
Amyris extends partnership with Kuraray for farnesene-based polymers
M2 - Mon Mar 31, 7:38AM CDT
Renewable products company Amyris (NasdaqGS:AMRS) said on Monday that it has extended its ongoing collaboration in high performance polymers using its brand of renewable farnesene.
Brazilian Airline GOL to Make First International Commercial Flights With Newly Approved Amyris-Total Aviation Biofuel
GlobeNewswire - Wed Jul 09, 7:00AM CDT
Amyris (Nasdaq:AMRS) has partnered with Brazilian airline GOL (NYSE:GOL) to begin the first commercial route with farnesane, the recently approved renewable jet fuel.
Should Amyris Investors Fear Intrexon's Farnesene?
Maxx Chatsko, The Motley Fool - Motley Fool - Mon Jul 07, 1:09PM CDT
When a company commercializes a building-block molecule with dozens, if not hundreds, of potential commercial uses, competition is bound to arrive sooner or later. When it comes to farnesene production, that competition may show up sooner than ...
What's the Value of Amyris' Molecule Development Strategy?
Maxx Chatsko, The Motley Fool - Motley Fool - Wed Jun 18, 11:50AM CDT
Artemisinin-based combination therapies are some of the most important weapons wielded by the developing world against malaria, which claims over 620,000 lives each year. While artemisinin is effective, its supply and cost is greatly affected by...
2014 Report on the International Synthetic Biology (Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms, DNA Synthesis, Oligonucleotide Synthesis) Market - Trends and Forecast to 2019
M2 - Wed Jun 18, 5:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9bcz55/synthetic_biology) has announced the addition of the "2014 Report on the International Synthetic Biology (Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms, DNA Synthesis, Oligonucleotide Synthesis) Market - Trends and Forecast to 2019" report to their offering. Synthetic biology defined as the synthesis of artificial or natural components in order to form new artificial living system by re-molding existing biological elements. It aims to attain new preferred functions of artificially modified organisms intended for high yield production of biological systems. Synthetic biology plays an important role in the field of life sciences by developing cheap synthesis procedures. Increasing scientific research coupled with introduction of advanced technologies in synthetic biology will drive the growth of this market. The market for synthetic biology is segmented as: by products, by technologies and by applications. Product segment includes core products and enabling products. Core product segment comprises synthetic DNA, synthetic genes, synthetic cells, XNA and chassis organisms. While enabling products are segmented into DNA and oligonucleotide synthesis products. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Synthetic Biology Market, by Products Chapter 5 Global Synthetic Biology Market, by Technologies Chapter 6 Global Synthetic Biology Market, by Applications Chapter 7 Global Synthetic Biology Market, by Geography Chapter 8 Competitive Landscape Chapter 9 Recommendations Chapter 10 Company Profiles Companies Mentioned: - Agrivida, Inc. - Amyris, Inc. - Algenol Biofuels, Inc. - ATG:biosynthetics GmbH - Bayer AG - Bristol-Myers Squibb - BIONEER CORPORATION - Biosearch Technologies, Inc. - CBC Comprehensive Biomarker Center GmbH - Cobalt Technologies - DuPont, Inc. - Evolva SA - Exxon Mobil Corporation - Ginkgo Bioworks - GeneWorks Pty Ltd. - Genomatica, Inc. - GeneScript Corporation - Gevo, Inc. - Green Biologics Limited - New England Biolabs, Inc. - OriGene Technologies, Inc. - REG Life Sciences, LLC - Royal DSM - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/9b...ic_biology
Amyris Up 5.2%, Shares Break Through Resistance (AMRS)
Comtex SmarTrend(R) - Tue Jun 17, 11:39AM CDT
Amyris (NASDAQ:AMRS) is one of today's best performing low-priced stocks, up 5.2% to $3.85 on 1.2x average daily volume. Thus far today, Amyris has traded 326,000 shares, vs. average volume of 269,000 shares per day. The stock has outperformed the Dow (5.2% to the Dow's 0.1%) and outperformed the S&P 500 (5.2% to the S&P's 0.1%) during today's trading.
Total and Amyris Renewable Jet Fuel Ready for Use in Commercial Aviation
GlobeNewswire - Mon Jun 16, 6:55AM CDT
With the newly revised ASTM standard for jet fuel, Amyris (Nasdaq:AMRS) and Total (CAC:TOTF.PA) today begin to prepare to market a drop-in jet fuel that contains up to 10% blends of renewable farnesane.
A Warning for Biofuel Investors
Shamus Funk, The Motley Fool - Motley Fool - Thu Jun 12, 9:57AM CDT
It's hard to believe a company producing and selling shark liver oil and low-friction tire rubber could be telling a story that we've already heard before, but Amyris ' tale is one not unseen in the bio-product industry. Like a poorly written...
Takasago and Amyris to Begin Commercialization of Novel Fragrance Products
GlobeNewswire - Mon Jun 09, 6:12AM CDT
Takasago (TYO:4914), a global leader in the creation of flavors and fragrances for consumer products, and Amyris (Nasdaq:AMRS), a leading renewable products company, today announced the start of the next phase of their relationship to commercialize farnesene-derived fragrance molecules. Having successfully completed feasibility testing, Takasago agreed to move forward with commercialization, starting with a first purchase for scale-up this quarter.
The Good, the Bad, and the Ugly From Amyris' Financing Deal
Maxx Chatsko, The Motley Fool - Motley Fool - Wed May 28, 3:39PM CDT
Here's a list of words that were not uttered during the first-quarter conference call of synthetic biology leader Amyris on May 8: "Financing" "Convertible debt notes" "$90 million" Although it wasn't discussed on the call, the company...
Why Amyris Inc's Shares Jumped Today
Travis Hoium, The Motley Fool - Motley Fool - Fri May 23, 4:55PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Amyris Inc jumped 12% today after...
Amyris Prices $75 Million Convertible Senior Notes Due 2019
GlobeNewswire - Fri May 23, 6:00AM CDT
Amyris, Inc. (Nasdaq:AMRS) today announced that it has priced $75 million aggregate principal amount of 6.50% Convertible Senior Notes due 2019 (the "notes"
. The notes will be sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. Amyris also granted the initial purchaser of the notes an option to purchase up to an additional $15 million aggregate principal amount of the notes. The sale is expected to close on May 29, 2014, subject to customary closing conditions. Why Amyris, Total SA, and The Boeing Company Are Excited About Renewable Jet Fuel
Maxx Chatsko, The Motley Fool - Motley Fool - Thu May 22, 8:42AM CDT
Boeing 777 aircraft (and more) around the world could soon be powered in part by renewable fuels. Source: United Airlines / Wikimedia Commons . The global aviation industry accounts for roughly 2% of all greenhouse gas emissions. On a per-passenger...
Amyris to Offer $75 Million Convertible Senior Notes Due 2019
GlobeNewswire - Thu May 22, 6:37AM CDT
Amyris, Inc. (Nasdaq:AMRS), a leading renewable chemicals and fuels company, today announced that it proposes to offer $75 million aggregate principal amount of Convertible Senior Notes due 2019 (the "notes"
, subject to market conditions and other factors. The notes are to be offered and sold in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. Amyris also intends to grant to the initial purchaser of the notes an option to purchase up to an additional $15 million aggregate principal amount of notes. Can Amyris Walk Its Risky Tightrope and Reward Investors?
Maxx Chatsko, The Motley Fool - Motley Fool - Thu May 15, 10:38AM CDT
Synthetic biology pioneer Amyris and its investors discovered several errors in the initial approach to start and ramp the company's wholly owned facility in Brotas, Brazil. While those problems would have been exposed with or without a pristine...
Why Amyris Inc's Shares Popped Today
Travis Hoium, The Motley Fool - Motley Fool - Fri May 09, 5:24PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of renewable products company Amyris Inc ...
Amyris Reports First Quarter 2014 Financial Results
GlobeNewswire - Thu May 08, 3:48PM CDT
-- Strong operating performance with combined inflows from product sales and collaboration inflows of $17.9 million
Amyris Receives Roundtable on Sustainable Biomaterials (RSB) Sustainability Certification
GlobeNewswire - Wed May 07, 9:14AM CDT
Amyris, Inc. (Nasdaq:AMRS) has completed the Roundtable on Sustainable Biomaterials (RSB) certification process and has earned one of the most respected sustainability certifications in the world.
4 Stocks Under $10 Making Big Moves
at The Street - Wed Apr 02, 5:00AM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Why Amyris (AMRS) Shares Are Jumping Today
at The Street - Tue Apr 01, 3:00PM CDT
Shares of Amyris (AMRS) are jumping Tuesday following a report from the United States Maritime Administration that compared an Amyris Renewable Diesel Fuel mixture to regular ultralow sulfur diesel fuel, and found reduced air emission with not...
Amyris extends partnership with Kuraray for farnesene-based polymers
M2 - Mon Mar 31, 7:38AM CDT
Renewable products company Amyris (NasdaqGS:AMRS) said on Monday that it has extended its ongoing collaboration in high performance polymers using its brand of renewable farnesene.
(0)
(0)